Blood supply has faced periodic acute shortages driven by declining donation rates and disruption events affecting collection and processing capacity. While the blood products themselves are managed through a specialized donation and processing system distinct from general medical distribution, the broader ecosystem of transfusion service supplies — collection sets, testing reagents, storage and transport equipment — follows more conventional supply chain dynamics that hospital procurement teams do directly manage.
What Transfusion Services Directly Control
- Blood typing and compatibility testing reagent supply, which faces its own manufacturer concentration and periodic shortage risk independent of the blood product supply itself
- Storage and transport equipment, including temperature-controlled refrigeration and transport containers meeting strict regulatory validation requirements
- Collection and processing consumables for facilities operating their own donor collection programs alongside outside blood supplier relationships
Building Resilience Where It's Possible
Because the underlying blood product supply itself is largely outside an individual hospital's direct control, resilience efforts have focused heavily on optimizing utilization — reducing unnecessary transfusion through evidence-based ordering protocols — and ensuring the testing and processing supply chain supporting transfusion services doesn't become an independent point of failure layered on top of blood product scarcity itself.
Multi-Supplier Relationships
Facilities are increasingly maintaining relationships with multiple blood supplier organizations where regional availability allows, rather than relying on a single regional blood center exclusively — a diversification strategy that mirrors broader medical supply resilience practice, applied to a category with historically less redundancy built in.
Facilities managing transfusion service supply can review Healix Medical Supply's lab supplies catalog.
